A detailed history of Los Angeles Capital Management LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 1,663 shares of BDX stock, worth $374,424. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,663
Previous 1,663 -0.0%
Holding current value
$374,424
Previous $388,000 3.09%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$225.07 - $246.17 $586,982 - $642,011
-2,608 Reduced 61.06%
1,663 $388,000
Q1 2024

Apr 05, 2024

SELL
$233.45 - $247.73 $11,205 - $11,891
-48 Reduced 1.11%
4,271 $1.06 Million
Q4 2023

Feb 06, 2024

SELL
$232.24 - $267.23 $34,139 - $39,282
-147 Reduced 3.29%
4,319 $1.05 Million
Q3 2023

Nov 06, 2023

SELL
$254.9 - $283.59 $5.26 Million - $5.85 Million
-20,646 Reduced 82.22%
4,466 $1.15 Million
Q2 2023

Aug 03, 2023

SELL
$238.39 - $265.32 $4.54 Million - $5.05 Million
-19,037 Reduced 43.12%
25,112 $6.63 Million
Q1 2023

May 04, 2023

SELL
$229.71 - $259.35 $113,017 - $127,600
-492 Reduced 1.1%
44,149 $10.9 Million
Q4 2022

Feb 06, 2023

BUY
$218.29 - $256.91 $6.29 Million - $7.4 Million
28,809 Added 181.97%
44,641 $11.4 Million
Q3 2022

Nov 02, 2022

BUY
$51.03 - $264.23 $78,841 - $408,235
1,545 Added 10.81%
15,832 $3.53 Million
Q2 2022

Aug 05, 2022

BUY
$234.74 - $275.42 $276,523 - $324,444
1,178 Added 8.99%
14,287 $3.52 Million
Q1 2022

May 06, 2022

BUY
$243.64 - $270.48 $2.61 Million - $2.9 Million
10,705 Added 445.3%
13,109 $3.49 Million
Q4 2021

Feb 03, 2022

SELL
$230.08 - $250.94 $4.17 Million - $4.55 Million
-18,129 Reduced 88.29%
2,404 $605,000
Q3 2021

Nov 08, 2021

SELL
$232.72 - $256.47 $473,119 - $521,403
-2,033 Reduced 9.01%
20,533 $5.05 Million
Q2 2021

Aug 05, 2021

BUY
$232.65 - $254.58 $3.86 Million - $4.22 Million
16,580 Added 276.98%
22,566 $5.49 Million
Q1 2021

May 05, 2021

BUY
$232.09 - $256.88 $107,225 - $118,678
462 Added 8.36%
5,986 $1.42 Million
Q4 2020

Feb 04, 2021

SELL
$221.92 - $245.94 $414,990 - $459,907
-1,870 Reduced 25.29%
5,524 $1.38 Million
Q3 2020

Nov 02, 2020

SELL
$215.77 - $276.76 $1.28 Million - $1.64 Million
-5,931 Reduced 44.51%
7,394 $1.72 Million
Q2 2020

Aug 05, 2020

BUY
$219.9 - $263.41 $719,512 - $861,877
3,272 Added 32.55%
13,325 $3.11 Million
Q1 2020

May 04, 2020

SELL
$195.69 - $279.01 $2.71 Million - $3.86 Million
-13,840 Reduced 57.92%
10,053 $2.31 Million
Q4 2019

Feb 07, 2020

SELL
$236.45 - $266.82 $8.33 Million - $9.4 Million
-35,227 Reduced 59.59%
23,893 $6.5 Million
Q3 2019

Nov 07, 2019

SELL
$230.58 - $256.08 $1.18 Million - $1.31 Million
-5,104 Reduced 7.95%
59,120 $15 Million
Q2 2019

Jul 29, 2019

SELL
$217.4 - $246.08 $3.01 Million - $3.41 Million
-13,854 Reduced 17.74%
64,224 $16.2 Million
Q1 2019

Apr 25, 2019

SELL
$206.05 - $248.17 $12.7 Million - $15.3 Million
-61,525 Reduced 44.07%
78,078 $19.5 Million
Q4 2018

Feb 11, 2019

BUY
$204.73 - $257.93 $252,022 - $317,511
1,231 Added 0.89%
139,603 $31.5 Million
Q3 2018

Nov 05, 2018

BUY
$233.07 - $256.0 $186,922 - $205,312
802 Added 0.58%
138,372 $36.1 Million
Q2 2018

Jul 31, 2018

SELL
$208.1 - $233.85 $47.1 Million - $53 Million
-226,531 Reduced 62.22%
137,570 $33 Million
Q1 2018

Apr 27, 2018

SELL
$205.46 - $240.27 $10.7 Million - $12.5 Million
-52,097 Reduced 12.52%
364,101 $78.9 Million
Q4 2017

Feb 05, 2018

SELL
$189.0 - $222.64 $65.3 Million - $77 Million
-345,636 Reduced 45.37%
416,198 $89.1 Million
Q3 2017

Nov 06, 2017

SELL
$186.89 - $198.9 $19 Million - $20.2 Million
-101,430 Reduced 11.75%
761,834 $149 Million
Q2 2017

Aug 09, 2017

BUY
N/A
863,264
863,264 $168 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.